• Oct 5, 2026

  $29.67+2.31%

  The broad market, tracked by the S&P 500 ETF (SPY), rose 0.67% on the same session in which the stock rose 2.31% [1]. The stock therefore moved by more than the broad market, though the benchmark was also higher [1].

  • 1Broad market

• Oct 2, 2026

  $29.00-1.02%

  Rosen Law Firm issued a PR Newswire release reminding purchasers of Hims & Hers Health securities of a securities fraud lawsuit and inviting investors to seek a lead role in it [1]. The shares closed down 1.02%, and the item gives no figures or other developments for the session.

  • 1Pr Newswire

• Oct 1, 2026

  $29.30-1.64%

• Sep 30, 2026

  $29.79+3.80%

  Hims & Hers shares rose 3.80% while the S&P 500 ETF (SPY) moved -0.21% over the same session, so the gain was not shared by the broad market [2]. Volume was 1.6x the trailing 20-session average, and the stock traded between 29.09 and 31.03 [3]. A Robbins Geller Rudman & Dowd press release about a class action lawsuit deadline was published that day [1].

  • 1Pr Newswire
  • 2Broad market
  • 3Market data

• Sep 29, 2026

  $28.70-0.28%

• Sep 28, 2026

  $28.78-2.18%

  The decline came alongside a broad-market move, with the S&P 500 ETF (SPY) down 0.74% in the same session [1]. The company fell 2.18%, about three times as much as the broad market [1].

  • 1Broad market

• Sep 25, 2026

  $29.42+0.48%

Closing prices for HIMS. Summaries describe past sessions only and are not advice, a forecast or a recommendation.

Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.